Current strategies for the provision of safer plasma and its derivatives: an update
Transfus Apher Sci
.
2001 Dec;25(3):185-7.
doi: 10.1016/s1473-0502(01)00118-5.
Authors
J Seghatchian
1
,
J P Allain
Affiliation
1
National Blood Service, London & SE, UK. jseghatchian@hotmail.com
PMID:
11846136
DOI:
10.1016/s1473-0502(01)00118-5
No abstract available
MeSH terms
Blood Component Transfusion / methods
Blood Component Transfusion / standards*
Clinical Trials as Topic
Humans
Plasma / virology*
Safety